Literature DB >> 1633650

An HLA study in 74 Danish haemochromatosis patients and in 21 of their families.

N Milman1, N Graudal, L S Nielsen, K Fenger.   

Abstract

HLA-A and -B alleles in 74 Danish patients and 21 homozygous relatives with idiopathic haemochromatosis (IH) were compared with those in a sample of 1719 chromosomes from healthy Danish control subjects. The following alleles occurred with higher frequencies in IH compared to controls: A3: 53.6% vs. 15.1% (Pc less than 0.001); B7: 33.1% vs. 15.6% (Pc less than 0.001); B14: 6.9% vs. 3.0% (Pc greater than 0.05); B38: 5% vs. 0.9% (Pc greater than 0.05); B47: 4.0% vs. 0.4% (Pc greater than 0.05). Pedigree analyses disclosed 19 different haplotypes in IH subjects, compared to 286 haplotypes in controls. The following haplotypes occurred with higher frequency in IH compared to controls: A3,B5: 10.3% vs. 0.3% (Pc less than 0.001); A3,B7: 25.6% vs. 6.6% (Pc = 0.001); A3,B14: 3.4% vs. 0.6% (Pc greater than 0.05); A3,B47: 6.9% vs. 0.2% (Pc greater than 0.05). The major IH marker HLA-A3 was found in 56% of the haplotypes. The patterns of HLA-alleles associated with IH in Denmark show similarities to those in Central Europe, Australia, USA and Canada, being A3,B7 dominated and those in Central Sweden, England and Ireland, being A3,B14 dominated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633650     DOI: 10.1111/j.1399-0004.1992.tb03619.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  2 in total

1.  Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome.

Authors:  J E Nielsen; L N Jensen; K Krabbe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

2.  HLA haplotypes associated with hemochromatosis mutations in the Spanish population.

Authors:  Arantza Pacho; Esther Mancebo; Manuel J del Rey; Maria J Castro; Desamparados Oliver; Miguel García-Berciano; Luis González; Pablo Morales
Journal:  BMC Med Genet       Date:  2004-10-21       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.